Department of Chemistry, Wesleyan University , Lawn Avenue, Middletown, Connecticut 06459, United States.
Biochemistry. 2014 Oct 21;53(41):6530-8. doi: 10.1021/bi500970f. Epub 2014 Oct 10.
Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describes the synthesis, determination of the inhibitory activity, and analysis of the results from two α-(2-thiazolidinyl) boronic acids that are closer analogues of particular tetrahedral intermediates involved in β-lactamase and DD-peptidase catalysis than those previously described. One of them, 2-[1-(dihydroxyboranyl)(2-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid, is a direct analogue of the deacylation tetrahedral intermediates of these enzymes. These compounds are micromolar inhibitors of class C β-lactamases but, very unexpectedly, not inhibitors of class A β-lactamases. We rationalize the latter result on the basis of a new mechanism of boronic acid inhibition of the class A enzymes. A stable inhibitory complex is not accessible because of the instability of an intermediate on its pathway of formation. The new boronic acids also do not inhibit bacterial DD-peptidases (penicillin-binding proteins). This result strongly supports a central feature of a previously proposed mechanism of action of β-lactam antibiotics, where deacylation of β-lactam-derived acyl-enzymes is not possible because of unfavorable steric interactions.
特定的硼酸是丝氨酸酰胺水解酶的强四面体中间体/过渡态类似物抑制剂。这组酶包括细菌β-内酰胺酶和 DD-肽酶,其中已经开发出相当多的硼酸抑制剂。本文描述了两种α-(2-噻唑烷)硼酸的合成、抑制活性的测定以及结果分析,它们是β-内酰胺酶和 DD-肽酶催化中涉及的特定四面体中间体的更接近类似物,而不是以前描述的那些。其中一种,2-[1-(二羟基硼基)(2-苯乙酰氨基)甲基]-5,5-二甲基-1,3-噻唑烷-4-羧酸,是这些酶脱酰化四面体中间体的直接类似物。这些化合物是 C 类β-内酰胺酶的毫摩尔抑制剂,但令人惊讶的是,它们不是 A 类β-内酰胺酶的抑制剂。我们根据 A 类酶硼酸抑制的新机制解释了后者的结果。由于形成途径中间产物的不稳定性,无法获得稳定的抑制性复合物。新的硼酸也不能抑制细菌 DD-肽酶(青霉素结合蛋白)。这一结果强烈支持了以前提出的β-内酰胺抗生素作用机制的一个核心特征,即由于不利的空间相互作用,β-内酰胺衍生的酰-酶的脱酰化是不可能的。